CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin Pharmaceuticals, Inc. (Amex: JAV - News) announced that it intends to file today an amendment to its Annual Report on Form 10-K for the year ended December 31, 2006, that was originally filed with the Securities and Exchange Commission on March 16, 2007. The amendment solely reinserts an explanatory footnote to a table that was mistakenly omitted from the Supplementary Financial Information (Unaudited) with respect to the 2005 Quarterly results of operations which had been included in the Form 10-K for the year ended December 31, 2005. Other than the reinsertion of the footnote, there were no restatements or corrections of any previously reported financial statements or change to any other disclosures.
